"Don’t question me, I am science." That’s generally the gist of the government’s response to any criticism during the COVID-19 pandemic. Led by top bureaucrat Dr. Anthony Fauci, the government’s overconfidence was surpassed only by its hubris during the emergency where hundreds of independent reporters, fact-checkers and investigators, including media such as TrialSite News, tracked the real unfolding science, as opposed to the promulgation of one formal emergency response narrative.
How bad will the headlines have to get before the elected officials act to mitigate the damages of a failed vaccine compensation system? What will it take to ensure appropriate reform in vaccine compensation schemes such as those issued under the UK’s Vaccine Damage Payment Act or for that matter, even a more broken, dysfunctional system: the U.S. National Vaccine Injury Compensation Program (VICP)?
------------------------------------
Join The Conversation! | https://trialsitenews.com/
...
https://www.youtube.com/watch?v=xiFerXDtQXc
Diversity, Equity, and Inclusion (DEI) initiatives have had a profound negative impact on the American Corporate landscape, leading to numerous accusations of racist hiring practices. As DEI efforts face increasing legal challenges, this video explores the complex landscape of reverse racism and the significant legal battles that have emerged because of it.
...
https://www.youtube.com/watch?v=2WURmcurmYI
Join The Conversation! | https://trialsitenews.com/
Deaths are on the rise in China as the Omicron-driven surge continues unabated in infectious hot spots. Places such as Shanghai, over the last several weeks have witnessed an unprecedented city-wide lockdown of nearly 26 million people. The failings of China’s pandemic management continue, including the recent disclosure that municipal health workers bundled up for dead an elderly person. However, at a morgue located in the Shanghai Xinchangzheng welfare hospital, the person was discovered to be still alive. Multiple media such as CBS News report that the ongoing zero-tolerance policy and existing lockdowns are making the Chinese and world economy pay dearly.
Article Link | https://www.trialsitenews.com/p/trialsitenews/chinas-relentless-war-on-covid-19-has-causalitiesthe-people-economy-domestically-beyond-70a93fa9
...
https://www.youtube.com/watch?v=qPlApRJh7UM
Join The Conversation! | https://trialsitenews.com/
TrialSite News has done a series of articles on the subject of children and vaccines. For example, Pfizer applied for Emergency Use Authorization (EUA) for their Covid vaccine for children under 12 without clinical trials for the shot. Dr. Paul Offit of the Children’s Hospital of Philadelphia, a known vaccine expert, believes there was not enough testing done on the Covid vaccine when the only available information about the jab was “mouse” data. Even a Danish health official raised alarms about parents deciding to vaccinate their children. But a proposed bill in the state of Connecticut may take the vaccination decision out of the hands of parents.
...
https://www.youtube.com/watch?v=xv6JXMeFcP8
Join us as we go over our top stories from the week:
NCCN® 2019 in San Francisco: Latest Treatment Innovations for Hematologic Malignancies
PPD’s AES Acquires Global Site Business of Bioclinica to Become Large Aggregator of Sites Worldwide
NIH R61/R33 Trans-Agency Blood-Brain Interface Program (Clinical Trials Not Allowed)
Bayer’s Clinical Trials Device-Driven Future: Powered by the Oracle mHealth Connector Cloud Service
Columbia University and Clinical Trials: In Thy Light Shall We See the Light.
Pharma-Sponsored Oncology Trials Face Troubling Age Disparity Trend
CereHealth Brain Imaging Centers Selected by Denver Neurological Research for SPARC Phase II Parkinson’s Trial
Dangook University Hospital Center of Hair Loss Treatment Clinical Trial
UB & Tetra Therapeutics Collaborate to Study BPN14770 to Treat Alzheimer’s Disease
Swiss Biotechnology Company Anokion SA Achieves Major Acquisition and Funding, Providing Runway for Multiple Emerging Autoimmune Therapies
Harry Potter Author Donates £15.3m to Support MS Center at the University of Edinburgh
$15M Grant Awarded to Commercialize UC San Diego-Based Novel Vaccine for Strep Throat
St. Jude Children’s Research Hospital Completes Initial Stage of Phase I Trial Assessing GDC-0084 for Deadly Pediatric Brain Tumor
SMA Miracle Drug Creators Cited by the FDA For Data Manipulation
Time Stamps:
00:31– Cancer
01:24– Clinical Trials
06:49 – Neurological Disease
08:12 – Hairloss
08:47 – Alzheimer's Disease
09:44 – Autoimmune
11:18 – Strep Throat
12:54 – Brain Tumor
18:22 – SiteWatch Challenge
...
https://www.youtube.com/watch?v=dKAfASjENoo
In this must-watch episode of Pioneers, Shabnam Palesa Mohamed engages Dr. Peter McCullough (USA) on whether the WHO's pronouncements on Marburg mean the public should panic. Dr. Peter McCullough shares his insights on disease progression and potential treatments. We also discuss the level of trust the public should place in WHO recommendations.
------------------------------------
Join The Conversation! | https://trialsitenews.com/
...
https://www.youtube.com/watch?v=GoGD-kblBAs
Slovakia Becomes the First EU Nation to Formally Approve Ivermectin for Both Prophylaxis and Treatment for COVID-19 Patients:
The Slovakia Republic’s Minister of Health has formerly registered Ivermectin as an approved prophylaxis and treatment for SARS-CoV-2, the virus behind COVID-19. In breaking news, the authorization occurred as doctors received the news that they could proceed with formally authorized prescriptions both in hospitals and outpatient. On January 26, Health Minister Marek Krajci granted a permit for the unregistered drug as the drug has already been in use on a compassionate basis over the past half year. TrialSite interviewed Ondrej Halgas, a researcher from University of Toronto and originally from Slovakia. Halgas has been actively involved with a network organizing and lobbying for the drug’s approval during the pandemic.
https://trialsitenews.com/slovakia-becomes-the-first-eu-nation-to-formally-approve-ivermectin-for-both-prophylaxis-and-treatment-for-covid-19-patients/
...
https://www.youtube.com/watch?v=vcTHzt4O7OU
An Interview with Dr. Ian Smith, Founder, Director and Chief Medical Officer of Panthera Biopartners and CEO of Panthera Biopartners Stuart Young discussing the Lessons from Covid-19 and the differing strategies for recruiting and retaining patients in oncology and chronic diseases including CNS, Rheumatoid arthritis, Nash and cardiovascular.
About Panthera:
An independent site management organization run by a world-class team of experts, finds patients and runs clinical trials on behalf of CROs and pharma companies across multiple therapeutic areas.
https://www.panthera-bio.com/
About Dr. Ian Smith:
Dr. Ian founded Synexus, the world’s first independent clinical trials organization, whilst practicing as a GP. He went on to build the Synexus model into the foremost SMO with sites across the world.
Today Ian is a non-executive director of several healthcare companies. Ian was awarded an MBE for services to health research.
About CEO Stuart Young
Stuart previously managed the UK division of Synexus overseeing nine dedicated research sites. Stuart is particularly focused on the use of technology to reduce costs in clinical trials, provide a first rate patient experience and ensure that Panthera is at the cutting edge of clinical research.
Stuart, holds a degree in Mechanical Engineering from University of Strathclyde in Glasgow, has had extensive experience in data management and the introduction of new technologies into organizations.
...
https://www.youtube.com/watch?v=PReh9YRYzlg
Join The Conversation! | https://trialsitenews.com/
A scientist and expert witness shared with TrialSite News a recent legal case involving a 22-year Navy enlisted LT. The winning law firm, R Davis Younts Esquire, reports that on May 20, 2022, a Board composed of three Navy officers found that the firm’s client, LT Bill Moseley, did not commit misconduct by refusing a COVID-19 injection and found unanimously that LT Moseley should be retained in the United States Navy.
...
https://www.youtube.com/watch?v=A5vVhfXHkvw